DEAD

Serial Number

87660540

Owner

Genesis Drug Discovery & Development, LLC

Attorney

Christina E. Brule

First Use Date

Oct 18, 2017

Filing Date

Oct 26, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GD3 Trademark

Serial Number: 87660540 • Registration: 5657219

GD3 is a trademark filed by Genesis Drug Discovery & Development, LLC on October 26, 2017. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Genesis Drug Discovery & Development, LLC (14 trademarks)

2439 Kuser Road
Hamilton, NJ 08690

Entity Type: 16

Legal Representation

Attorney of Record

Christina E. Brule

177 trademarks filed View all →

Correspondence Address

Christina E. Brule Heslin Rothenberg Farley & Mesiti P.C.

5 Columbia Circle

Albany, NY 12203

United States

Trademark Details

Filing Date

October 26, 2017

Registration Date

January 15, 2019

First Use Anywhere

October 18, 2017

First Use in Commerce

October 24, 2017

Published for Opposition

April 3, 2018

Cancellation Date

July 25, 2025

Goods & Services

Scientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery

Filing History

CANCELLED SEC. 8 (6-YR)

Jul 25, 2025 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jan 15, 2024 REM1

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Sep 15, 2023 EWAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 15, 2023 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 15, 2023 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 15, 2023 REAP

REGISTERED-PRINCIPAL REGISTER

Jan 15, 2019 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 11, 2018 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 8, 2018 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Dec 8, 2018 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 8, 2018 AITU

USE AMENDMENT FILED

Nov 27, 2018 IUAF

TEAS STATEMENT OF USE RECEIVED

Nov 27, 2018 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 29, 2018 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 3, 2018 NPUB

PUBLISHED FOR OPPOSITION

Apr 3, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 14, 2018 NONP

ASSIGNED TO LIE

Feb 27, 2018 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 20, 2018 CNSA

EXAMINER'S AMENDMENT ENTERED

Feb 20, 2018 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 20, 2018 GNEN

EXAMINERS AMENDMENT E-MAILED

Feb 20, 2018 GNEA

EXAMINERS AMENDMENT -WRITTEN

Feb 20, 2018 CNEA

ASSIGNED TO EXAMINER

Feb 6, 2018 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 7, 2017 MDSM

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 4, 2017 NWOS

NEW APPLICATION ENTERED

Oct 30, 2017 NWAP

Related Trademarks

More from this Owner

IMMUNOVEDA

More in Same Class

Serial #87661136

RXPUSH

VEND

INTENSIFICATION ZONE

MASTERCARD AVENUE

SEQUENCING BY BINDING